Trials / Completed
CompletedNCT05246046
Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler
Pharmacokinetic Study to Compare Tiotropium Easyhaler® Product Variants and Spiriva® 18 µg Capsules Administered Via HandiHaler® in Healthy Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a pivotal study to investigate absorption of inhaled tiotropium from 2 Tiotropium Easyhaler product variants and Spiriva capsules inhaled via HandiHaler.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tiotropium Bromide Monohydrate | In each period, subjects receive single dose of tiotropium consisting of 2 inhaled doses via Easyhaler or 2 Spiriva capsules inhaled via HandiHaler |
Timeline
- Start date
- 2022-02-16
- Primary completion
- 2022-08-03
- Completion
- 2022-08-03
- First posted
- 2022-02-18
- Last updated
- 2022-08-18
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05246046. Inclusion in this directory is not an endorsement.